Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
very well said, Thanks!
We are the ONLY sub-cutaneous out there, so Trump MAY be talking about us!
IF approved, but YES, that is what he said!
He thinks they will get Breakthrough Therapy designation
to skip Phase 3 and get approval based on this data! They KNOW the data is AWESOME!
Now for CD-12 data:
EINDs
Meeting Monday August 3, results due next week
CD-10 Top line within 10 days or so
Goodbye!
CD10 - is working better in earlier phase of care than they initially thought.
Did he just say top line results to FDA in ten days?!!!
You get the feeling they are about to say, BUT Leronlemab can beat ALL these others!
Link not working?
They have had at least 14 days to cover if they chose to.
With all due respect, companies announce major news all day every day . . . just watch the news feed on any on your favorite channels or a platform like TOS. Stocks take off running PM, morning, evening, and AH, often based on news, so . . . yeah, this could be a very important news announcement - not discounting it just because it is not Monday morning!
Great news coming. Price leading the way.
One thing that I really like about PCTL is that there is no pattern to their PRs. You can't say once 6:30, or 7:00, or 7:30 or 4:00 passes, "well I guess no release today" - you just never know when it will come - they release PM, morning, afternoon, and even AH. Love it!
very well put together, sir. Nice quotes!
Unless the company is terribly mismanaged, and unless you cannot read the DD posted here re: numbers of distributors and producers and sellers and resellers, you should by now KNOW that this company is raking in some serious dough - as Gary said in (I believe) the last interview "we are funding the expansion from cash flow" - THAT IS A HUGE STATEMENT! You can literally BANK on it.
And we are going to have all three reports within the next three weeks or so . . . so boom, Boom, BOOM!
I don't have as many shares as I'd like. I have read much data, many PRs,financials, many posts here, and the excellent DD done by some. I can't shake the feeling that profits and revenue are being conservatively estimated. The list of clients and distributors (plus their clients) is quite long. Who really knows how much HOCL is being used across the country right now, and you can bet your sweet @$$ that IF schools and more businesses open in the Fall or in the Spring, demand will skyrocket. I think the Q1 may surprise a bit, but the Q2 even more. I'll crawl back in my hole for now.
Thanks. So best case (8/10) or a week from next Monday for Q2, which would suggest 10-K and Q1 earlier - worst case all done by 8/17.
So let me get this straight:
By mid-August we should have 10k and Q1, with Q2 shortly after?
I'm reading here that the IR guy is confident the Q2 will nearly be on time,correct?
Looks like .049 is the majik number - just keeps producing shares as it gets hit.
We could be at .05 pretty quickly . . .
Thanks for putting this together. It is the sort of thing that gets lost in the weeds in a lively discussion!
I feel that just because you have the therapy that will "save the world" doesn't get you to the head of the line.
One fun thing about this company is that they do not have a set pattern for when they release news. It could come PM, in the morning, after noon, or AH.
The clearer this picture becomes, the more the shorts do their thing. Someone wants to load this bigly at a low price, and if it costs them some interest payments to do so, well . . . so be it! Maybe Big Money is using Big Pharma's attack to invest heavily in CYDY . . . ?
Knowing what we know about leronlimab, at what price is the stock too expensive?
Thank you
Thank you
Thank you.
Very good, relevant questions. I have the same.
Don't forget why you bought CYDY.
Scrutiny is part of the game. Frustration with poorly worded PRs is okay too. Naked shorting, stock manipulation, political wrangling, spin doctoring . . . all part of the landscape.
BUT
The science works and can save many lives and help make the future a little brighter in many ways.
Come on, NASDAQ!
Once we get the first approval, I see the stock clearing $30 pretty quickly, at which time they can start selling a million or two shares here and there to raise clinical money. If the govt. kicks in a few tens of millions for development or production, we can be knocking on $100 pretty fairly soon (given regulatory lag time). At some point the shorts will have to give up or risk huge losses, imo.
Welcome Odwell!
On the other hand, there are several large companies with LOTS at stake if Leronlimab gets approved for even one indication. LOTS! I have no doubt they have hired every gun out there to try to dissuade investors from pitching in with CYDY. It is possible that the price action reflects the realization that the data was very good, and thus deep pockets are scared spitless!
And with approval, the first profit taking will occur around what price? $30 $40 $50 $60? And I'm not even joking . . .
I'm betting most of those shares will get sold north of $30
NP indicates on the latest video that they will be discussing data tomorrow and taking questions.
Re: LaTane's post
Why not create a signatory list of people from this site and others to support LaTane's letter? It is as well-worded as can be written, and most of us agree with it, so why not add the power of a few stockholders behind it?
So true . . . there is not even a glass!
For now, lets get the financial out and PCTL will start to fly, but prepare for business as usual to become very different than it was before Covid-19.